Jim Cramer - Mad Money Ulta Salon Cosmetics and Fragrance Inc. ULTA-Q COMMENT Mar 07, 2025

They had a great quarter and he loves the CEO. At $438, shares are in no-man's land. Sells at 17x earnings. A good buy, but not a trading stock.

#2 in cosmetics, behind ELF Beauty.

They're positioned well in beauty and benefits from the Instagram Effect. It reports next week.

EPS of $8.08 beat estimates of $7.57. Revenue of $3.55B beat estimates by 6.7%. EBITDA of $579M beat by 5.6%. Conservative guidance worried investors, though. Ulta Beauty's outlook for more operating-margin deterioration in fiscal 2024 is a bit of a concern, given the metric fell more than 100 bps to 15% in 2023 and since big market-cap hardline peers are largely projecting improvement this year. Beauty demand remains robust, as evidenced by strong 4Q results, including a 14.6% operating margin -- up vs. 3Q and above management's guidance. This strength in demand should let discounts remain limited, a tailwind for margin. The company's forecast for $11.7-$11.8 billion in sales for 2024 appears low, implying less than 5% growth at the midpoint, or about half of 2023's almost 10% gain. This might be too drastic a slowdown, even with tough year-over-year comparisons, considering its growing customer base and expanding store fleet. We are comfortable still, but it needs to be watched a bit more closely than usual. 
Unlock Premium - Try 5i Free

Revenues are up 22% over 3 year, but only 6% in the past year. Shares are down 24% in the past 12 months. It's a maturing stock.

It reports Thursday. But he keeps hearing Sephora is eating into their business, and that ULTA is not doing so well.

Underperforming. Great specialty beauty retailer in the US, partners with Target. Chart's a roller-coaster, too volatile for her. You can trade it if you want, get in and get out, but she's staying away.

Is worried because competitor ELF reported such a bad quarter.

All of the downside is priced in, seeing upward movement from a technical perspective. Underperformed major indexes by a fair amount, now showing signs of turnaround for a value play. Great product, good distribution channels. No dividend.